Format

Send to

Choose Destination
Br J Haematol. 2017 Jul 24. doi: 10.1111/bjh.14817. [Epub ahead of print]

Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study.

Author information

1
USI Università della Svizzera Italiana (USI), Institute of Oncology Research (IOR), Bellinzona.
2
Oncology Institute of Southern Switzerland, Bellinzona (IOSI).
3
Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
4
Ematologia, A.O.U. Citta della Salute e della Scienza di Torino, Turin, Italy.
5
Dalle Molle Institute for Artificial Intelligence (IDSIA), Manno, Switzerland.
6
Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO-Piemonte), Turin, Italy.
7
Statistical Bioinformatics, Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
8
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
9
Department of Molecular Biotechnology and Health Science and Center for Experimental Research and Medical Studies (CeRMS), University of Torino, Torino, Italy.
10
Department of Pathology, NYU Cancer Center, New York University School of Medicine, New York, NY, USA.

KEYWORDS:

Nanostring; diffuse large B cell lymphoma; gene expression; lenalidomide; lymphoma

PMID:
28737236
DOI:
10.1111/bjh.14817

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center